• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玩转杂环的开环与闭环:利用库斯马诺-鲁恰反应开发一类新型恶二唑并噻嗪酮,作为钙通道调节剂和P-糖蛋白抑制剂具有活性。

Playing with opening and closing of heterocycles: using the cusmano-ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and P-glycoprotein inhibitors.

作者信息

Spinelli Domenico, Budriesi Roberta, Cosimelli Barbara, Severi Elda, Micucci Matteo, Baroni Massimo, Fusi Fabio, Ioan Pierfranco, Cross Simon, Frosini Maria, Saponara Simona, Matucci Rosanna, Rosano Camillo, Viale Maurizio, Chiarini Alberto, Carosati Emanuele

机构信息

Dipartimento di Chimica "G. Ciamician", Alma Mater Studiorum-Università di Bologna, Via F. Selmi 2, Bologna 40126, Italy.

Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum-Università di Bologna, Via Belmeloro 6, Bologna 40126, Italy.

出版信息

Molecules. 2014 Oct 14;19(10):16543-72. doi: 10.3390/molecules191016543.

DOI:10.3390/molecules191016543
PMID:25317581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6271282/
Abstract

As a result of the ring-into-ring conversion of nitrosoimidazole derivatives, we obtained a molecular scaffold that, when properly decorated, is able to decrease inotropy by blocking L-type calcium channels. Previously, we used this scaffold to develop a quantitative structure-activity relationship (QSAR) model, and we used the most potent oxadiazolothiazinone as a template for ligand-based virtual screening. Here, we enlarge the diversity of chemical decorations, present the synthesis and in vitro data for 11 new derivatives, and develop a new 3D-QSAR model with recent in silico techniques. We observed a key role played by the oxadiazolone moiety: given the presence of positively charged calcium ions in the transmembrane channel protein, we hypothesize the formation of a ternary complex between the oxadiazolothiazinone, the Ca2+ ion and the protein. We have supported this hypothesis by means of pharmacophore generation and through the docking of the pharmacophore into a homology model of the protein. We also studied with docking experiments the interaction with a homology model of P-glycoprotein, which is inhibited by this series of molecules, and provided further evidence toward the relevance of this scaffold in biological interactions.

摘要

由于亚硝基咪唑衍生物的环内环转化,我们获得了一种分子支架,经过适当修饰后,该支架能够通过阻断L型钙通道来降低心肌收缩力。此前,我们利用该支架建立了定量构效关系(QSAR)模型,并将最有效的恶二唑并噻嗪酮用作基于配体的虚拟筛选模板。在此,我们扩大了化学修饰的多样性,展示了11种新衍生物的合成及体外数据,并利用最新的计算机技术建立了新的3D-QSAR模型。我们观察到恶二唑酮部分发挥的关键作用:鉴于跨膜通道蛋白中存在带正电荷的钙离子,我们推测恶二唑并噻嗪酮、Ca2+离子和蛋白质之间形成了三元复合物。我们通过药效团生成以及将药效团对接至蛋白质的同源模型来支持这一假设。我们还通过对接实验研究了与P-糖蛋白同源模型的相互作用,该系列分子可抑制P-糖蛋白,并为该支架在生物相互作用中的相关性提供了进一步证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/7462680a754e/molecules-19-16543-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/b6d84a908cc8/molecules-19-16543-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/c0e4d6a2cdf1/molecules-19-16543-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/b77fc96a40fd/molecules-19-16543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/3c9cafbf56cd/molecules-19-16543-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/22841d423323/molecules-19-16543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/ebdb12ec2e62/molecules-19-16543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/743dc94512b7/molecules-19-16543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/3c9f41d7ec71/molecules-19-16543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/2c87e9f8852e/molecules-19-16543-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/875c7f22b4f7/molecules-19-16543-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/7462680a754e/molecules-19-16543-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/b6d84a908cc8/molecules-19-16543-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/c0e4d6a2cdf1/molecules-19-16543-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/b77fc96a40fd/molecules-19-16543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/3c9cafbf56cd/molecules-19-16543-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/22841d423323/molecules-19-16543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/ebdb12ec2e62/molecules-19-16543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/743dc94512b7/molecules-19-16543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/3c9f41d7ec71/molecules-19-16543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/2c87e9f8852e/molecules-19-16543-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/875c7f22b4f7/molecules-19-16543-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbc/6271282/7462680a754e/molecules-19-16543-g008.jpg

相似文献

1
Playing with opening and closing of heterocycles: using the cusmano-ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and P-glycoprotein inhibitors.玩转杂环的开环与闭环:利用库斯马诺-鲁恰反应开发一类新型恶二唑并噻嗪酮,作为钙通道调节剂和P-糖蛋白抑制剂具有活性。
Molecules. 2014 Oct 14;19(10):16543-72. doi: 10.3390/molecules191016543.
2
Identification and Investigation of Chalcone Derivatives as Calcium Channel Blockers: Pharmacophore Modeling, Docking Studies, In vitro Screening, and 3D-QSAR Analysis.查尔酮衍生物作为钙通道阻滞剂的鉴定与研究:药效团建模、对接研究、体外筛选及三维定量构效关系分析
Curr Comput Aided Drug Des. 2021;17(5):676-686. doi: 10.2174/1573409916666200714143930.
3
Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.硝基氧烷基 1,4-二氢-2,6-二甲基-3-硝基-4-(2,1,3-苯并恶二唑-4-基)吡啶-5-羧酸酯外消旋体、对映体和非对映体的合成、钙通道激动剂-拮抗剂调节活性及一氧化氮释放研究
J Med Chem. 2004 Jan 1;47(1):254-61. doi: 10.1021/jm030333h.
4
Calcium channel antagonists discovered by a multidisciplinary approach.通过多学科方法发现的钙通道拮抗剂。
J Med Chem. 2006 Aug 24;49(17):5206-16. doi: 10.1021/jm0604373.
5
A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives.一类新型的选择性心肌钙通道调节剂。2. 缩醛链在恶二唑-3-酮衍生物中的作用。
J Med Chem. 2005 Apr 7;48(7):2445-56. doi: 10.1021/jm0493414.
6
Synthesis and L-type calcium channel blocking activity of new chiral oxadiazolothiazinones.新型手性噁二唑并噻嗪酮的合成及 L 型钙通道阻断活性。
Eur J Med Chem. 2015 Mar 6;92:481-9. doi: 10.1016/j.ejmech.2014.12.044. Epub 2014 Dec 25.
7
Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.烷基(或环烷基)1,4-二氢-2,6-二甲基-3-硝基-4-吡啶基-5-吡啶羧酸酯外消旋体和对映体的合成及其钙通道调节作用
J Med Chem. 1998 Feb 12;41(4):509-14. doi: 10.1021/jm9704006.
8
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.L型钙通道阻滞剂:从地尔硫䓬到经由噻嗪并恶二唑-3-酮衍生物的1,2,4-恶二唑-5-酮类化合物。
J Med Chem. 2009 Apr 23;52(8):2352-62. doi: 10.1021/jm801351u.
9
Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.1,4 - 二氢吡啶类钙通道阻滞剂的合成、对接模拟、生物学评价及三维定量构效关系研究
Chem Pharm Bull (Tokyo). 2017;65(10):893-903. doi: 10.1248/cpb.c17-00186.
10
Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors.基于配体和结构的 P-糖蛋白抑制剂预测分类模型。
J Chem Inf Model. 2014 Jan 27;54(1):218-29. doi: 10.1021/ci400289j. Epub 2014 Jan 9.

引用本文的文献

1
(1,3)-1,4-Dinitro-1,3-butadiene-Synthesis, Spectral Characteristics and Computational Study Based on MEDT, ADME and PASS Simulation.(1,3)-1,4-二硝基-1,3-丁二烯——基于分子能量密度理论、药物代谢动力学和预毒性预测模拟的合成、光谱特征及计算研究
Molecules. 2024 Jan 22;29(2):542. doi: 10.3390/molecules29020542.
2
3-Aryl-4-nitrobenzothiochromans -dioxide: From Calcium-Channel Modulators Properties to Multidrug-Resistance Reverting Activity.3-芳基-4-硝基苯并噻二嗪二酮:从钙通道调节剂特性到多药耐药逆转活性。
Molecules. 2020 Feb 27;25(5):1056. doi: 10.3390/molecules25051056.

本文引用的文献

1
Synthesis and L-type calcium channel blocking activity of new chiral oxadiazolothiazinones.新型手性噁二唑并噻嗪酮的合成及 L 型钙通道阻断活性。
Eur J Med Chem. 2015 Mar 6;92:481-9. doi: 10.1016/j.ejmech.2014.12.044. Epub 2014 Dec 25.
2
ABCB1 Structural Models, Molecular Docking, and Synthesis of New Oxadiazolothiazin-3-one Inhibitors.ABCB1结构模型、分子对接以及新型恶二唑并噻嗪-3-酮抑制剂的合成
ACS Med Chem Lett. 2013 May 13;4(8):694-8. doi: 10.1021/ml300436x. eCollection 2013 Aug 8.
3
L-type Ca(2+) channel current characteristics are preserved in rat tail artery myocytes after one-day storage.
L 型钙通道电流特性在大鼠尾动脉心肌细胞储存一天后得以保留。
Acta Physiol (Oxf). 2014 Jun;211(2):334-45. doi: 10.1111/apha.12282. Epub 2014 Apr 23.
4
GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation.基于网格的三维药效团 I:FLAPpharm,一种新的药效团解析方法。
J Chem Inf Model. 2012 Oct 22;52(10):2587-98. doi: 10.1021/ci300153d. Epub 2012 Sep 21.
5
Mechanism of osthole inhibition of vascular Ca(v)1.2 current.蛇床子素抑制血管钙通道电流的机制。
Eur J Pharmacol. 2012 Apr 5;680(1-3):22-7. doi: 10.1016/j.ejphar.2012.01.038. Epub 2012 Feb 4.
6
FLAP: GRID molecular interaction fields in virtual screening. validation using the DUD data set.FLAP:虚拟筛选中的网格分子相互作用场。使用 DUD 数据集进行验证。
J Chem Inf Model. 2010 Aug 23;50(8):1442-50. doi: 10.1021/ci100221g.
7
Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: toward new candidates.一类新型地尔硫䓬类似物对多药耐药蛋白1(MDR1)活性的体外抑制作用:寻找新的候选药物
J Med Chem. 2009 Jan 22;52(2):259-66. doi: 10.1021/jm801195k.
8
[Knowledge of nitrothiazole compounds].[关于硝基噻唑化合物的知识]
Helv Chim Acta. 1947 Dec 1;30(7):2110-3. doi: 10.1002/hlca.19470300726.
9
Molecular modeling of benzothiazepine binding in the L-type calcium channel.苯并硫氮䓬在L型钙通道中结合的分子模拟
J Biol Chem. 2008 Jun 20;283(25):17594-604. doi: 10.1074/jbc.M800141200. Epub 2008 Apr 8.
10
A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application.用于分析/比较蛋白质和配体的通用参考框架。配体和蛋白质指纹图谱(FLAP):理论与应用。
J Chem Inf Model. 2007 Mar-Apr;47(2):279-94. doi: 10.1021/ci600253e.